[go: up one dir, main page]

AR007648A1 - Forma de dosis farmaceutica de gelatina blanda, de fases multiples - Google Patents

Forma de dosis farmaceutica de gelatina blanda, de fases multiples

Info

Publication number
AR007648A1
AR007648A1 ARP970102858A ARP970102858A AR007648A1 AR 007648 A1 AR007648 A1 AR 007648A1 AR P970102858 A ARP970102858 A AR P970102858A AR P970102858 A ARP970102858 A AR P970102858A AR 007648 A1 AR007648 A1 AR 007648A1
Authority
AR
Argentina
Prior art keywords
phases
dosage form
pharmaceutical dosage
phase
multiple phases
Prior art date
Application number
ARP970102858A
Other languages
English (en)
Original Assignee
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc
Publication of AR007648A1 publication Critical patent/AR007648A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Una forma de dosis farmacéutica de gelatina blanda, de fases múltiples, que comprende: una envolvente común de material polimérico; una primer faseque comprende un primer material de relleno semisólido; una segunda fase que comprende un segundo material de relleno semisólido; y por lo menos una dedichas fases primera y segundo contiene un ingrediente activo; cada una de las fases primera y segunda está dispuesta en regiones discretas de la envolventey en contacto mutuo en al menos una interfase; difiriendo las fases primera y segunda en su composición y por lo menos una de dichas fases tiene una turbidezde menos de 1,300 UTN.
ARP970102858A 1996-06-28 1997-06-27 Forma de dosis farmaceutica de gelatina blanda, de fases multiples AR007648A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/671,979 US6024980A (en) 1996-06-28 1996-06-28 Multiphase soft gelatin dosage form

Publications (1)

Publication Number Publication Date
AR007648A1 true AR007648A1 (es) 1999-11-10

Family

ID=24696660

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970102858A AR007648A1 (es) 1996-06-28 1997-06-27 Forma de dosis farmaceutica de gelatina blanda, de fases multiples

Country Status (24)

Country Link
US (1) US6024980A (es)
EP (1) EP0815855B1 (es)
JP (1) JPH10182437A (es)
KR (1) KR980000438A (es)
CN (1) CN1172642A (es)
AR (1) AR007648A1 (es)
AT (1) ATE223707T1 (es)
AU (1) AU2620197A (es)
BR (1) BR9703771A (es)
CO (1) CO4900025A1 (es)
CZ (1) CZ205697A3 (es)
DE (1) DE69715319T2 (es)
DK (1) DK0815855T3 (es)
ES (1) ES2183089T3 (es)
HU (1) HUP9701113A2 (es)
ID (1) ID17794A (es)
IL (1) IL121145A0 (es)
NO (1) NO972963L (es)
NZ (1) NZ328182A (es)
PL (1) PL320815A1 (es)
PT (1) PT815855E (es)
SG (1) SG54525A1 (es)
TN (1) TNSN97111A1 (es)
ZA (1) ZA975767B (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
CN1183904C (zh) * 1999-02-26 2005-01-12 盐野义制药株式会社 改进了服用性的咀嚼型软胶囊剂及其制法
US20030060422A1 (en) 2001-08-31 2003-03-27 Balaji Venkataraman Tannate compositions and methods of treatment
AU2002330285A1 (en) * 2001-09-18 2003-04-01 The North West University Triclosan dosage form
US8128957B1 (en) 2002-02-21 2012-03-06 Valeant International (Barbados) Srl Modified release compositions of at least one form of tramadol
US20050182056A9 (en) * 2002-02-21 2005-08-18 Seth Pawan Modified release formulations of at least one form of tramadol
US7670612B2 (en) * 2002-04-10 2010-03-02 Innercap Technologies, Inc. Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
AU2003272601B2 (en) * 2002-09-20 2009-05-07 Alpharma Pharmaceuticals, Llc Sustained-release opioid formulations and methods of use
FR2850275B1 (fr) * 2003-01-24 2005-04-08 Scherer Technologies Inc R P Capsules molles a macher contenant une substance active a gout masque
US20040185032A1 (en) * 2003-03-18 2004-09-23 David Burrell Compositions and methods for treating colic
US7201920B2 (en) 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
US20050249802A1 (en) * 2004-05-06 2005-11-10 The Procter & Gamble Company Softgel encapsulated pharmaceutical compositions comprising concentrated active ingredients
US20070036859A1 (en) * 2005-08-11 2007-02-15 Perry Ronald L Sustained release antihistamine and decongestant composition
WO2011041414A1 (en) * 2009-09-30 2011-04-07 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse
JP2015512945A (ja) * 2012-04-13 2015-04-30 バナー ファーマキャップス，インコーポレイティド 錠剤と液体または半固体の充填剤とを含む軟質弾性カプセル、ならびにそれらの製造方法
MX392839B (es) 2012-11-30 2025-03-24 Acura Pharmaceuticals Inc Liberacion autorregulada de ingrediente farmaceutico activo.
HK1218622A1 (zh) 2013-03-15 2017-03-03 Warner Chilcott Company, Llc 含有改性瓜尔胶的药物软明胶胶囊剂型
AU2014306759B2 (en) 2013-08-12 2018-04-26 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US10172797B2 (en) 2013-12-17 2019-01-08 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
WO2015145459A1 (en) 2014-03-26 2015-10-01 Sun Pharma Advanced Research Company Ltd. Abuse deterrent immediate release coated reservoir solid dosage form
DK3169315T3 (da) 2014-07-17 2020-08-10 Pharmaceutical Manufacturing Res Services In Væskefyldt doseringsform til forhindring af misbrug med øjeblikkelig frigivelse
WO2016064873A1 (en) 2014-10-20 2016-04-28 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
US11103581B2 (en) 2015-08-31 2021-08-31 Acura Pharmaceuticals, Inc. Methods and compositions for self-regulated release of active pharmaceutical ingredient
CA3091678A1 (en) * 2018-02-26 2019-08-29 R.P. Scherer Technologies, Llc Pharmaceutical dosage form for an emulsion of simethicone and loperamide
CA3110496A1 (en) * 2018-08-31 2020-03-05 Arctic Therapeutics, Llc Novel topical formulation for intradermal application and uses thereof

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59131355A (ja) * 1983-01-17 1984-07-28 森下仁丹株式会社 多重軟カプセルの製法
US4486412A (en) * 1983-03-15 1984-12-04 Pharmacaps, Inc. Encapsulated antacid dispersions
WO1986004501A1 (fr) * 1985-01-31 1986-08-14 Fujisawa Pharmaceutical Co., Ltd. Capsule souple a cavites multiples; son procede et appareil de fabrication
JPS61189230A (ja) * 1985-02-19 1986-08-22 Nippon Kayaku Co Ltd エトポシド製剤
GB8507779D0 (en) * 1985-03-26 1985-05-01 Fujisawa Pharmaceutical Co Drug carrier
US4639846A (en) * 1985-08-16 1987-01-27 Bbc Brown, Boveri & Company, Limited Method and compensating device for compensating current oscillations
US5209978A (en) * 1985-12-26 1993-05-11 Taisho Pharmaceutical Co., Ltd. Seamless soft capsule and production thereof
DE3600084A1 (de) * 1986-01-03 1987-07-09 Scherer Gmbh R P Formkoerper sowie verfahren und vorrichtung zur herstellung eines solchen formkoerpers
US4708834A (en) * 1986-05-01 1987-11-24 Pharmacaps, Inc. Preparation of gelatin-encapsulated controlled release composition
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
DE3727894A1 (de) * 1987-08-21 1989-03-02 Stephan Dieter Kapsel fuer pharmazeutisch wirksame inhaltsstoffe einer droge
FR2624012B1 (fr) * 1987-12-07 1991-05-31 Fdb Ste Civile Rech Nouvelles compositions pharmaceutiques a action hypnotique a base d'hydrate de chloral
US4956184A (en) * 1988-05-06 1990-09-11 Alcide Corporation Topical treatment of genital herpes lesions
US4935243A (en) * 1988-12-19 1990-06-19 Pharmacaps, Inc. Chewable, edible soft gelatin capsule
US5073384A (en) * 1989-10-19 1991-12-17 Valentine Enterprises, Inc. Maltodextrin/defoaming composition combinate
GB8926612D0 (en) * 1989-11-24 1990-01-17 Erba Farmitalia Pharmaceutical compositions
IE64128B1 (en) * 1990-02-26 1995-07-12 Byrne Rynne Holdings Ltd A pharmaceutical composition
GB9022788D0 (en) * 1990-10-19 1990-12-05 Cortecs Ltd Pharmaceutical formulations
GR1002332B (el) * 1992-05-21 1996-05-16 Mcneil-Ppc Inc. Νεες φαρμακευτικες συνθεσεις που περιεχουν σιμεθεικονη.
US5501857A (en) * 1992-07-24 1996-03-26 Midwestern Bio-Ag Products & Services, Inc. Oral nutritional and dietary composition
US5683716A (en) * 1993-06-30 1997-11-04 Fujisawa Pharmaceutical Co., Ltd. Encapsulated medicine
US5725846A (en) * 1995-03-02 1998-03-10 The Gillette Company Clear antiperspirant stick containing dibenzylidene alditol and hydroxyalkyl cellulose

Also Published As

Publication number Publication date
MX9704846A (es) 1998-07-31
IL121145A0 (en) 1997-11-20
EP0815855A1 (en) 1998-01-07
ATE223707T1 (de) 2002-09-15
HU9701113D0 (en) 1997-08-28
PT815855E (pt) 2003-01-31
CZ205697A3 (cs) 1998-01-14
TNSN97111A1 (fr) 2005-03-15
DE69715319T2 (de) 2003-01-23
JPH10182437A (ja) 1998-07-07
NZ328182A (en) 1998-11-25
DK0815855T3 (da) 2003-01-06
NO972963D0 (no) 1997-06-25
CO4900025A1 (es) 2000-03-27
ZA975767B (en) 1998-12-28
KR980000438A (ko) 1998-03-30
SG54525A1 (en) 1998-11-16
DE69715319D1 (de) 2002-10-17
HUP9701113A2 (hu) 1998-08-28
PL320815A1 (en) 1998-01-05
ID17794A (id) 1998-01-29
BR9703771A (pt) 1998-09-01
NO972963L (no) 1997-12-29
CN1172642A (zh) 1998-02-11
EP0815855B1 (en) 2002-09-11
ES2183089T3 (es) 2003-03-16
AU2620197A (en) 1998-01-15
US6024980A (en) 2000-02-15

Similar Documents

Publication Publication Date Title
AR007648A1 (es) Forma de dosis farmaceutica de gelatina blanda, de fases multiples
BR0212951A (pt) Formas de dosagens compósitas
ES2039480T3 (es) Una forma de dosificacion liquida para administracion oral de una sustancia farmaceuticamente activa.
ATE270544T1 (de) Halbfeste arzneizubereitung enthaltend isotretinoin
ATE554750T1 (de) Hydrophobe pharmazeutische wirkstoffe enthaltende zubereitungen
ES2087964T3 (es) Contraceptivos orales bajos en estrogenos.
CO4890840A1 (es) Materiales de relleno para forma de dosis farmaceuticas de gelatina blanda y formas de dosis farmaceuticas que las con- tienen
ATE224717T1 (de) Oral anzuwendende arzneizubereitungen enthaltend eine benzhydrylpiperazine und eine zyklodextrin
DE122010000030I2 (de) Verbindungen von wirkstoffen, welche klopidogrel und antithrombotische mittel enthalten.
BR9714465A (pt) Composição, utilização de uma associação e utilização de um silicone polioxialquilenado
BR0112080A (pt) Vetores particulados para aperfeiçoamento da absorção oral de principios ativos
EP0983994A3 (de) Dimethyl-(3-aryl-but-3-enyl)-aminverbindungen als pharmazeutische Wirkstoffe
ES2173595T3 (es) Encapsulado de ingredientes activos.
ES2168457T3 (es) Composiciones farmaceuticas que comprenden una superoxido dismutasa.
BR9906285A (pt) Manocápsulas, composição cosméticas ou dermatológica, e, processo de preparação das manocápsulas
WO2001001931A3 (de) Parfümhaltiges mittel zur behandlung der haare oder der haut mit zwei phasen
DE69908139D1 (de) Waschmitteltabletten und deren Herstellung
BR9810285A (pt) Solução, composição farmacêutica, e, cápsula de gelatina.
BR9506389B1 (pt) composto de silìcio, e, composição dietética, cosmética e terapêutica.
DE3788195D1 (de) DIBENZ[b,e]OXEPINDERIVATE, SOWIE ARZNEIMITTEL, DIE DIESE ALS AKTIVE MITTEL ENTHALTEN.
AR007650A1 (es) Composicion farmaceutica para forma de dosis farmaceutica de gelatina blanda y forma de dosis que la comprende
BR9910454A (pt) Preparações efervescentes
DE59506611D1 (de) Befüllung von pharmazeutischen mehrkammerverpackungen
ATE256457T1 (de) In gelatine eingekapselte sertarline dosierungsformen
DZ3103A1 (fr) Nouvelles pyrazolo Ä4,3-EÜdiazépines substituées, compositions pharmaceutiques les contenant, utili sation à titre de médicament et procédés pour leurs préparation.